Search results
COVID-19 booster immunity lasts much longer than primary series alone, study shows
Medical Xpress· 5 days agoThe study used Canadian vaccine data collected from individuals living in long-term care, as well as frontline health-care workers working in long-term...
MedWatch Digest: A booster is better at promoting immunity — and more
WGN TV Chicago· 1 day agoFor Monday, April 22, WGN’s Dina Bair the latest on new medical information.
China's drugmakers can't sell mRNA shots but haven't quit yet
Colorado Springs Gazette· 5 days agoChina's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are...
Eye on IPRs, April 2024: PTAB’s Analogous Art Finding Upheld by Federal Circuit, Blockchain Gemstone...
JD Supra· 6 days agoAs IP Watchdog reported, the U.S. Court of Appeals for the Federal Circuit denied Daedalus Blue LLC’s appeal of a Patent Trial and Appeal Board (PTAB) ruling that found claims of U.S. Patent ...
Nucleic Acid-based Therapeutics Market to Reach USD 14.25 Billion by 2031 Driven by Surge in...
Digital Journal· 6 days agoThe demand for nucleic acid-based therapeutics has soared in recent years due to their effectiveness...
FDA expands Pfizer boosters for more teens as omicron surges
AOL· 5 days agoThe U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12. Boosters already are ...
Peninsula VC adds more than $100 million, brings on former Pfizer exec as partner - San Francisco...
The Business Journals· 6 days agoA leading biotech venture capital firm said it's added more than $100 million in capital and a seasoned industry voice in former Pfizer Inc. executive Uwe Schoenbeck. The new cash, from limited ...
Biotechnology and Pharmaceuticals
The Wall Street Transcript· 6 days ago(ADR) ( OTCMKTS:RHHBY ), Moderna ( NASDAQ:MRNA ), BioNTech SE (ADR) ( NASDAQ:BNTX ), Bristol-Myers Squibb Company ( NYSE:BMY ), Novartis AG ( NYSE:NVS ), Cabaletta Bio Inc ...
